Opportunity Information: Apply for PA 08 189

  • The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Integrating Biobehavioral and Sociocultural Research to Prevent HIV Transmission and Infection (R21)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242 Mental Health Research Grants 93.279 Drug Abuse and Addiction Research Programs 93.361 Nursing Research 93.856 Microbiology and Infectious Diseases Research.
  • This funding opportunity was created on Dec 5, 2008 and posted on Jun 30, 2008.
  • Applicants must submit their applications by May 7, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $200,000.00 in funding.
  • Eligible applicants include: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities City or township governments County governments Native American tribal organizations (other than Federally recognized tribal governments) State governments Public and State controlled institutions of higher education Private institutions of higher education Special district governments Others (see text field entitled Additional Information on Eligibility for clarification).
  • Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
Apply for PA 08 189

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The NIH grant opportunity "Integrating Biobehavioral and Sociocultural Research to Prevent HIV Transmission and Infection (R21)" (Funding Opportunity Number PA-08-189) supports early-stage, exploratory research aimed at preventing HIV infection and reducing HIV transmission by combining biobehavioral science with a serious, context-specific understanding of culture. The main idea is that prevention strategies work better when they are not only biologically and behaviorally sound, but also designed and tested in ways that reflect the real norms, beliefs, values, and lived experiences of the communities most affected by HIV. The FOA emphasizes that culture is not static, so applicants are expected to approach sociocultural factors as dynamic and shaped by changing social, economic, political, and interpersonal conditions, whether the research is based in the United States or internationally.

A key feature of the announcement is its push for "theoretically grounded" prevention approaches. This means proposals should not just test an intervention or collect data in an ad hoc way, but should be built on a clear conceptual framework that explains how biological and behavioral mechanisms interact with social and cultural influences to affect HIV risk and prevention outcomes. The FOA defines biobehavioral approaches broadly. On one end, projects may be explicitly biomedical (for example, prevention tools or strategies grounded in biological mechanisms). On the other end, projects may be behavioral interventions that incorporate biological markers as evidence of efficacy or mechanism, rather than relying only on self-reported behavior change. In practice, that can include using biomarkers or clinical endpoints (such as seroconversion or other relevant biological measures) to help determine whether an intervention is actually affecting HIV-related outcomes.

The FOA welcomes intervention studies and "pre-intervention" studies, signaling interest both in testing prevention strategies and in conducting preparatory research that improves the design, acceptability, feasibility, or ethical implementation of future interventions. At the same time, NIH makes clear that descriptive work is still needed in some areas, particularly ethnographic and epidemiological studies that can map how cultural and social variables shape behaviors and biological risk. Examples given include research that clarifies how cultural factors may either impede or support movement toward desirable biological outcomes (with seroconversion referenced as an example endpoint), research that strengthens understanding of ethical concerns in biomedical prevention studies, and research that identifies barriers to adherence that may not be obvious without deeper sociocultural investigation. In other words, applicants can propose studies that explain problems (like why adherence fails in a specific context), as well as studies that test solutions, but both types of projects should connect sociocultural realities to biological and behavioral processes relevant to HIV prevention.

For intervention-focused proposals, the FOA stresses that efficacy should be evaluated in light of sociocultural context. That emphasis is important because it frames "what works" as inseparable from "for whom, under what conditions, and why." Applicants are encouraged to examine how local norms, stigma, relationship patterns, gender dynamics, economic constraints, community trust, and health system realities influence uptake and sustained use of biomedical prevention tools or behavioral programs that have biological endpoints. The overall expectation is that integrating sociocultural knowledge will improve not only scientific quality, but also the practical applicability of findings across diverse populations affected by the HIV pandemic.

This is an R21 mechanism, meaning it is designed for exploratory and developmental projects rather than large, definitive trials. The listed award ceiling is $200,000, and the announcement specifies no cost sharing or matching requirement. The funding instrument type is a grant, and the opportunity is categorized as discretionary. The activity category is listed under education and health, and the CFDA program areas include mental health research (93.242), drug abuse and addiction research programs (93.279), nursing research (93.361), and microbiology and infectious diseases research (93.856), reflecting how HIV prevention work often crosses disciplinary boundaries spanning behavioral health, substance use, clinical science, and infectious disease research.

Eligibility is broad and includes many kinds of organizations that might be positioned to do culturally grounded HIV prevention work. Eligible applicants include public and private institutions of higher education, nonprofits with or without 501(c)(3) status (with the noted exception categories), small businesses, and for-profit organizations (including those other than small businesses). Government entities at multiple levels are also eligible, including state governments, county governments, city or township governments, special district governments, public housing authorities/Indian housing authorities, and federally recognized tribal governments, as well as tribal organizations that are not federally recognized. The FOA also explicitly includes a range of mission-focused and capacity-building institution types, such as HBCUs, Hispanic-serving institutions, tribally controlled colleges and universities (TCCUs), Alaska Native and Native Hawaiian serving institutions, faith-based and community-based organizations, and U.S. territories or possessions. Foreign (non-U.S.) entities and regional organizations are also listed as eligible, reinforcing that NIH is open to international HIV prevention studies when scientifically justified.

The opportunity was posted June 30, 2008, with an original and current closing date of May 7, 2011, and an archive date of June 7, 2011. The sponsoring agency is the National Institutes of Health. The full announcement was available via the NIH grants guide at the provided link (http://grants.nih.gov/grants/guide/pa-files/PA-08-189.html), and the contact listed for access or technical problems is the NIH Office of Extramural Research webmaster (FBOWebmaster@OD.NIH.GOV).

Frequently Asked Questions (FAQs)

What is the purpose of the NIH grant "Integrating Biobehavioral and Sociocultural Research to Prevent HIV Transmission and Infection (R21)" (PA-08-189)?

This funding opportunity supports early-stage, exploratory research intended to prevent HIV infection and reduce HIV transmission by integrating biobehavioral science with a context-specific understanding of culture. The focus is on designing and testing prevention approaches that reflect the norms, beliefs, values, and lived experiences of communities most affected by HIV.

What does it mean to "integrate biobehavioral and sociocultural research" in an HIV prevention study?

It means proposals should connect biological and behavioral mechanisms to social and cultural influences that shape HIV risk and prevention outcomes. The FOA encourages work that shows how prevention strategies function in real-world settings where factors like stigma, gender dynamics, relationship patterns, economic constraints, and community trust influence uptake and sustained use.

How does the FOA define "culture," and how should applicants address it?

The FOA emphasizes that culture is not static. Applicants are expected to treat sociocultural factors as dynamic and shaped by changing social, economic, political, and interpersonal conditions, whether research is conducted in the United States or internationally.

What does "theoretically grounded" mean in the context of this FOA?

Projects should be built on a clear conceptual framework rather than being ad hoc. The framework should explain how biological and behavioral mechanisms interact with social and cultural influences to affect HIV risk and prevention outcomes.

What kinds of biobehavioral approaches are allowed under this FOA?

The FOA defines biobehavioral approaches broadly. Projects may be explicitly biomedical (grounded in biological mechanisms) or behavioral interventions that incorporate biological markers as evidence of efficacy or mechanism, not relying solely on self-reported behavior change.

Does the FOA encourage the use of biomarkers or clinical endpoints?

Yes. The FOA highlights incorporating biomarkers or clinical endpoints (with seroconversion referenced as an example endpoint) to help determine whether an intervention is affecting HIV-related outcomes, rather than depending only on self-reported outcomes.

Are intervention studies allowed, or is this only for descriptive research?

Both are welcomed. The FOA welcomes intervention studies as well as "pre-intervention" studies. It also notes that descriptive work remains important in some areas, including ethnographic and epidemiological studies that map how cultural and social variables shape behavior and biological risk.

What are "pre-intervention" studies under this announcement?

Pre-intervention studies are preparatory efforts that improve the design, acceptability, feasibility, or ethical implementation of future interventions. They are intended to strengthen eventual intervention work by addressing context-specific issues before launching a full test of a prevention strategy.

What types of descriptive studies does the FOA say are still needed?

The FOA points to ethnographic and epidemiological studies that clarify how cultural and social variables shape behaviors and biological risk. It also mentions descriptive research that identifies barriers to adherence that may not be obvious without deeper sociocultural investigation.

Does the FOA support research on ethical concerns in biomedical prevention studies?

Yes. The FOA includes examples of research that strengthens understanding of ethical concerns in biomedical prevention studies, particularly when ethical issues are shaped by local sociocultural realities.

How does this FOA define "what works" in HIV prevention?

For intervention-focused proposals, the FOA stresses that efficacy should be evaluated in light of sociocultural context. That framing treats effectiveness as inseparable from questions like for whom an approach works, under what conditions, and why.

What kinds of sociocultural factors does the FOA highlight as important for prevention outcomes?

The FOA specifically encourages examining how local norms, stigma, relationship patterns, gender dynamics, economic constraints, community trust, and health system realities influence uptake and sustained use of prevention tools or programs.

What grant mechanism is used for this opportunity?

This opportunity uses the NIH R21 mechanism, which is designed for exploratory and developmental projects rather than large, definitive trials.

What is the maximum award amount listed for this R21 opportunity?

The listed award ceiling is $200,000.

Is cost sharing or matching required?

No. The announcement specifies no cost sharing or matching requirement.

What is the funding instrument type and how is the opportunity categorized?

The funding instrument type is a grant, and the opportunity is categorized as discretionary.

What activity category is associated with this opportunity?

The activity category is listed under education and health.

Which CFDA program areas are connected to this FOA?

The CFDA program areas listed include mental health research (93.242), drug abuse and addiction research programs (93.279), nursing research (93.361), and microbiology and infectious diseases research (93.856), reflecting the cross-disciplinary nature of HIV prevention research.

Who is eligible to apply?

Eligibility is broad. Eligible applicants include public and private institutions of higher education, nonprofits with or without 501(c)(3) status (with noted exception categories), small businesses, and for-profit organizations (including those other than small businesses). Multiple government entities are eligible as well.

Which government entities are specifically listed as eligible applicants?

Eligible government entities include state governments, county governments, city or township governments, special district governments, public housing authorities/Indian housing authorities, federally recognized tribal governments, and tribal organizations that are not federally recognized.

Are mission-focused and capacity-building institutions included in eligibility?

Yes. The FOA explicitly includes HBCUs, Hispanic-serving institutions, tribally controlled colleges and universities (TCCUs), Alaska Native and Native Hawaiian serving institutions, faith-based and community-based organizations, and U.S. territories or possessions.

Are foreign (non-U.S.) entities eligible to apply?

Yes. Foreign (non-U.S.) entities and regional organizations are listed as eligible, indicating NIH openness to international HIV prevention studies when scientifically justified.

When was this opportunity posted, and when did it close?

The opportunity was posted on June 30, 2008. The original and current closing date listed is May 7, 2011. The archive date is June 7, 2011.

Which agency sponsors this FOA?

The sponsoring agency is the National Institutes of Health (NIH).

Where was the full announcement published?

The full announcement was available via the NIH Grants Guide at http://grants.nih.gov/grants/guide/pa-files/PA-08-189.html.

Who should be contacted for access or technical problems related to the announcement?

The listed contact for access or technical problems is the NIH Office of Extramural Research webmaster at FBOWebmaster@OD.NIH.GOV.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education Health

Next opportunity: Geographic and Contextual Influences on Energy Balance Related Health Behaviors (R01)

Previous opportunity: Integrating Biobehavioral and Sociocultural Research to Prevent HIV Transmission and Infection (R01)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PA 08 189

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PA 08 189) also looked into and applied for these:

Funding Opportunity
Geographic and Contextual Influences on Energy Balance Related Health Behaviors (R01) Apply for PA 08 192

Funding Number: PA 08 192
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Geographic and Contextual Influences on Energy Balance Related Health Behaviors (R21) Apply for PA 08 193

Funding Number: PA 08 193
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Technological Innovations for Interdisciplinary Research Incorporating the Behavioral and Social Sciences (STTR R41/R42) Apply for PAR 08 201

Funding Number: PAR 08 201
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Pilot studies in Pancreatic Cancer (R21) Apply for PA 08 208

Funding Number: PA 08 208
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
PPilot studies in Pancreatic Cancer (R03) Apply for PA 08 209

Funding Number: PA 08 209
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Diet Induced Changes in Inflammation as Determinants of Colon Cancer (R01) Apply for PA 08 210

Funding Number: PA 08 210
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Diet Induced Changes in Inflammation as Determinants of Colon Cancer (R21) Apply for PA 08 211

Funding Number: PA 08 211
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
Drug Abuse Prevention Intervention Research (R01) Apply for PA 08 217

Funding Number: PA 08 217
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Drug Abuse Prevention Intervention Research (R21) Apply for PA 08 218

Funding Number: PA 08 218
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
Drug Abuse Prevention Intervention Research (R03) Apply for PA 08 219

Funding Number: PA 08 219
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Investigational Nutrigenetic Studies for Cancer Prevention (R01) Apply for PA 08 220

Funding Number: PA 08 220
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Investigational Nutrigenetic Studies for Cancer Prevention (R21) Apply for PA 08 221

Funding Number: PA 08 221
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
Etiology, Prevention, and Treatment of Hepatocellular Carcinoma(R21) Apply for PA 08 244

Funding Number: PA 08 244
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
Central Nervous System Intersections of Drug Addiction, Chronic Pain and Analgesia (R03) Apply for RFA DA 09 019

Funding Number: RFA DA 09 019
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Central Nervous System Intersections of Drug Addiction, Chronic Pain and Analgesia (R01) Apply for RFA DA 09 017

Funding Number: RFA DA 09 017
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Physical Science Oncology Centers (U54) Apply for RFA CA 09 009

Funding Number: RFA CA 09 009
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $2,250,000
NINR Mentored Research Scientist Development Award for Underrepresented or Disadvantaged Investigators (K01) Apply for PAR 05 135

Funding Number: PAR 05 135
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $20,000
NCI Transition Career Development Award to Promote Diversity (K22) Apply for PAR 08 047

Funding Number: PAR 08 047
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
NINR Career Transition Award (K22) Apply for PAR 08 148

Funding Number: PAR 08 148
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Research on the Cognitive Sequelae of Parkinsons Disease (R01) Apply for PA 09 033

Funding Number: PA 09 033
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PA 08 189", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.